Pravastatin Sodium NDC 69292-104

NDC codes

FDA NDC Directory

Product NDC (as listed)69292-104Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69292-0104Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
69292-104-10	69292010410	1000 TABLET in 1 BOTTLE (69292-104-10)Marketed from May 19, 2026
69292-104-50	69292010450	500 TABLET in 1 BOTTLE (69292-104-50)Marketed from May 19, 2026
69292-104-90	69292010490	90 TABLET in 1 BOTTLE (69292-104-90)Marketed from May 19, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Pravastatin Sodium
Generic name (nonproprietary): pravastatin sodium
Active ingredients: Pravastatin sodium — 80 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Amici Pharma, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077491
Marketing start: May 19, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Hydroxymethylglutaryl-CoA Reductase Inhibitors (Mechanism)
Identifiers: Product ID 69292-104_52351ef8-7a5a-6e07-e063-6294a90af72aSPL ID 52351ef8-7a5a-6e07-e063-6294a90af72aSPL set ID e6551230-fe4c-4a6e-9c19-ae9945b76db0RxCUI 904458, 904467, 904475, 904481UNII 3M8608UQ61
Pharmacologic class: HMG-CoA Reductase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469292010410 followed by a unit qualifier and the quantity

Package 69292-0104-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 19, 2026.

Indications (excerpt from the label)

Pravastatin sodium tablets is indicated: • To reduce the risk of myocardial infarction, myocardial revascularization procedures, and cardiovascular mortality in adults with elevated low-density lipoprotein cholesterol (LDL-C) without clinically evident coronary heart disease (CHD). • To reduce the risk of coronary death, myocardial infarction, myocardial revascularization procedures, stroke or transient ischemic attack, and slow the progression of coronary atherosclerosis in adults with clinically evident CHD. • As an adjunct to diet to reduce LDL-C in adults with primary hyperlipidemia. • As an adjunct to diet to reduce LDL-C in pediatric patients ages 8 years and older with heterozygous fa…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 077491

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077491
Product	Strength	Form · route	Labeler	Product NDC
Pravastatin Sodium	Pravastatin sodium 10 mg/1	TabletOral	Amici Pharma, Inc.	69292-101
Pravastatin Sodium	Pravastatin sodium 20 mg/1	TabletOral	Amici Pharma, Inc.	69292-102
Pravastatin Sodium	Pravastatin sodium 40 mg/1	TabletOral	Amici Pharma, Inc.	69292-103